| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Common Stock | 434K | $5.61M | $12.93 | May 29, 2024 | By the Eckelman Living Trust Dated February 5, 2014 |
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Common Stock | 40K | $517K | $12.93 | May 29, 2024 | By trust |
| Inhibrx, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By the Eckelman Living Trust dated February 5, 2014 |
| Inhibrx, Inc. | Chief Scientific Officer | Common Stock | 0 | $0 | $30.00 | May 30, 2024 | By trust |
| Inhibrx, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 0 | $0 | $34.12 | May 30, 2024 | Direct |
| Inhibrx Biosciences, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 175K | May 30, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INXB | Inhibrx Biosciences, Inc. | May 29, 2024 | 4 | $0 | 4 | May 30, 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | May 28, 2024 | 6 | -$72M | 4 | May 30, 2024 | Chief Scientific Officer |
| INXB | Inhibrx Biosciences, Inc. | May 24, 2024 | 0 | $0 | 3 | May 24, 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | May 22, 2024 | 2 | -$171K | 4 | May 24, 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Mar 13, 2024 | 1 | -$67.1K | 4 | Mar 15, 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Mar 8, 2024 | 5 | -$1.4M | 4 | Mar 12, 2024 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Mar 1, 2023 | 2 | -$968K | 4 | Mar 2, 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Feb 1, 2023 | 5 | -$997K | 4 | Feb 2, 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Jan 3, 2023 | 6 | -$949K | 4 | Jan 4, 2023 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Dec 6, 2022 | 3 | -$1.09M | 4 | Dec 7, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Nov 1, 2022 | 2 | -$1.34M | 4 | Nov 2, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Oct 4, 2022 | 7 | -$1.11M | 4 | Oct 5, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Sep 13, 2022 | 3 | $0 | 4 | Sep 14, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Sep 6, 2022 | 2 | -$596K | 4 | Sep 7, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Aug 2, 2022 | 2 | -$720K | 4 | Aug 4, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Jul 7, 2022 | 1 | -$687K | 4 | Jul 8, 2022 | Chief Scientific Officer |
| INBX | Inhibrx, Inc. | Apr 5, 2022 | 1 | -$10K | 4 | Apr 7, 2022 | Chief Scientific Officer |